Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Retrospective Analysis to Evaluate Switching to Raltegravir Plus Abacavir/Lamivudine in HIV-1-Infected Patients. ORASWIRAL Study

NCT02708342 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT02708342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02708342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Retrospective Analysis to Evaluate Switching to Raltegravir Plus Abacavir/Lamivudine in HIV-1-Infected Patients. ORASWIRAL Study
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
December 31, 2016
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv